AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 161 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $81,000 | -36.2% | 40,000 | 0.0% | 0.01% | -25.0% |
Q2 2022 | $127,000 | -24.0% | 40,000 | 0.0% | 0.01% | -11.1% |
Q1 2022 | $167,000 | -13.0% | 40,000 | 0.0% | 0.01% | 0.0% |
Q4 2021 | $192,000 | -10.3% | 40,000 | 0.0% | 0.01% | -18.2% |
Q3 2021 | $214,000 | +4.4% | 40,000 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $205,000 | -23.8% | 40,000 | 0.0% | 0.01% | -26.7% |
Q1 2021 | $269,000 | +47.0% | 40,000 | 0.0% | 0.02% | +36.4% |
Q4 2020 | $183,000 | +18.1% | 40,000 | 0.0% | 0.01% | -15.4% |
Q3 2020 | $155,000 | -18.4% | 40,000 | 0.0% | 0.01% | -23.5% |
Q2 2020 | $190,000 | +36.7% | 40,000 | 0.0% | 0.02% | +21.4% |
Q1 2020 | $139,000 | -28.0% | 40,000 | 0.0% | 0.01% | -6.7% |
Q4 2019 | $193,000 | +168.1% | 40,000 | +300.0% | 0.02% | +150.0% |
Q2 2019 | $72,000 | -49.3% | 10,000 | 0.0% | 0.01% | -53.8% |
Q1 2019 | $142,000 | +5.2% | 10,000 | 0.0% | 0.01% | -13.3% |
Q4 2018 | $135,000 | -39.2% | 10,000 | 0.0% | 0.02% | -21.1% |
Q3 2018 | $222,000 | +35.4% | 10,000 | 0.0% | 0.02% | +11.8% |
Q2 2018 | $164,000 | – | 10,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fosun International Ltd | 21,521,301 | $83,503,000 | 7.34% |
Eversept Partners, LP | 2,656,208 | $10,306,087 | 2.29% |
TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $62,908,000 | 1.13% |
Prosight Management, LP | 512,659 | $1,989,000 | 0.95% |
THB ASSET MANAGEMENT | 833,104 | $3,232,000 | 0.90% |
GLOBEFLEX CAPITAL L P | 251,696 | $977,000 | 0.26% |
XTX MARKETS LLC | 10,243 | $40,000 | 0.19% |
HUSSMAN STRATEGIC ADVISORS, INC. | 102,000 | $396,000 | 0.10% |
PA Capital LLC | 33,874 | $132,000 | 0.09% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 60,900 | $236,000 | 0.07% |